Submitted by Anonymous (not verified) on 2 October 2024 - 14:37
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 13, Status: Authorised